PAVmed (PAVM) Research & Development (2015 - 2025)

PAVmed's Research & Development history runs 11 years deep, the most recent figure standing at $1.8 million for Q4 2025.

• In Q4 2025, Research & Development rose 126.52% year-over-year to $1.8 million; the TTM figure through Dec 2025 stood at $4.5 million (down 43.72% YoY), while the FY2025 annual figure was $4.5 million, down 24.28% from the prior year.
• Research & Development was $1.8 million for Q4 2025 at PAVmed, up from $1.1 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $7.0 million in Q4 2021 to a low of $787000.0 in Q1 2025.
• Historically, Research & Development has averaged $3.6 million across 5 years, with a median of $3.5 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Research & Development sank 77.55% in 2024, then soared 126.52% in 2025.
• A 5-year view of Research & Development shows it stood at $7.0 million in 2021, then decreased by 4.23% to $6.7 million in 2022, then slumped by 46.13% to $3.6 million in 2023, then sank by 77.55% to $807000.0 in 2024, then jumped by 126.52% to $1.8 million in 2025.
• The last three Research & Development figures came in at $1.8 million (Q4 2025), $1.1 million (Q3 2025), and $790000.0 (Q2 2025), per Business Quant data.